LOCALISATION OF ENDOCRINE-RELATED TUMOURS WITH RADIOIODINATED ANALOGUE OF SOMATOSTATIN
- 4 February 1989
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 333 (8632), 242-244
- https://doi.org/10.1016/s0140-6736(89)91258-0
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- In vitro and in vivo inhibition of human small cell lung carcinoma (NCl-H69) growth by a somatostatin analogueBiochemical and Biophysical Research Communications, 1988
- Potential role of somatostatin analogues in the treatment of cancerEuropean Journal of Clinical Investigation, 1987
- Treatment of the Malignant Carcinoid SyndromeThe New England Journal of Medicine, 1986
- High Incidence of Somatostatin Receptors in Human Meningiomas: Biochemical CharacterizationJournal of Clinical Endocrinology & Metabolism, 1986
- Studies on the Mechanism of Action of the Inhibitory Effect of the Somatostatin Analog SMS 201–995 on the Growth of the Prolactin/Adrenocorticotropin-Secreting Pituitary Tumor 7315aEndocrinology, 1986
- Long-Term Treatment of Acromegaly with the Somatostatin Analogue SMS 201–995The New England Journal of Medicine, 1985
- The Somatostatin Analog SMS 201-995 Induces Long-Acting Inhibition of Growth Hormone Secretion without Rebound Hypersecretion in Acromegalic Patients*Journal of Clinical Endocrinology & Metabolism, 1985
- A somatostatin analogue inhibits chondrosarcoma and insulinoma tumour growthActa Endocrinologica, 1985
- Effect of a Long-Acting Somatostatin Analogue (SMS 201–995) in a Patient with Pancreatic CholeraThe New England Journal of Medicine, 1985
- High Density of Somatostatin Receptors in Pituitary Tumors from Acromegalic PatientsJournal of Clinical Endocrinology & Metabolism, 1984